SPRC
Scisparc LtdNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.93M
P/E Ratio
0.00
EPS
$3156.52
Beta
1.33
52W High
$94.50
52W Low
$3.30
50-Day MA
$5.22
200-Day MA
$27.16
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Scisparc Ltd
SciSparc Ltd., a specialized clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. The company is headquartered in Tel Aviv, Israel.
Fundamentals
| Revenue (TTM) | $1.31M |
| Gross Profit (TTM) | 506,000 |
| EBITDA | $-7.03M |
| Operating Margin | -570.00% |
| Return on Equity | -1281.00% |
| Return on Assets | -99.20% |
| Revenue/Share (TTM) | $42.38 |
| Book Value | $142.32 |
| Price-to-Book | 0.49 |
| Price-to-Sales (TTM) | 1.48 |
| EV/Revenue | 2.795 |
| EV/EBITDA | 1.21 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -45.10% |
| Shares Outstanding | 565,500 |
| Float | 46,620 |
| % Insiders | 8.56% |
| % Institutions | 1.13% |
Historical Volatility
HV 10-Day
63.67%
HV 20-Day
100.86%
HV 30-Day
146.03%
HV 60-Day
119.78%
HV Rank
—
Volatility is currently contracting
Data last updated: 4/9/2026